From: A molecular signature for the prediction of recurrence in colorectal cancer
Parameters | No. of patients | Univariate | Multivariate | ||
---|---|---|---|---|---|
P value | HR (95% CI) | P value | HR (95% CI) | ||
Gender | Â | 0.303 | 1.321 (0.778-2.243) | 0.940 | 1.022 (0.571-1.830) |
Male | 117 | Â | Â | Â | Â |
Female | 83 | Â | Â | Â | Â |
Age | Â | 0.889 | 0.963 (0.656-1.641) | 0.161 | 0.662 (0.372-1.178) |
<60 | 113 | Â | Â | Â | Â |
> = 60 | 87 |  |  |  |  |
Tumor size | Â | 0.323 | 1.323 (0.759-2.308) | 0.450 | 1.260 (0.692-2.296) |
<5 | 141 | Â | Â | Â | Â |
> = 5 | 59 |  |  |  |  |
Location | Â | 0.376 | 0.776 (0.442-1.362) | 0.895 | 0.961 (0.533-1.734) |
Colon | 77 | Â | Â | Â | Â |
Rectal | 123 | Â | Â | Â | Â |
Gross appearance | Â | 0.820 | 1.062 (0.631-1.788) | 0.599 | 0.863 (0.499-1.493) |
Exophytic | 39 | Â | Â | Â | Â |
Ulcerative | 5 | Â | Â | Â | Â |
Infiltrative | 156 | Â | Â | Â | Â |
Differentiation | Â | 0.440 | 1.269 (0.693-2.323) | 0.546 | 1.227 (0.631-2.388) |
High | 6 | Â | Â | Â | Â |
Moderate | 153 | Â | Â | Â | Â |
Low | 41 | Â | Â | Â | Â |
Stage | Â | <0.001 | 3.568 (1.912-6.660) | 0.701 | 1.243 (0.410-3.764) |
II | 95 | Â | Â | Â | Â |
III | 105 | Â | Â | Â | Â |
T stage | Â | 0.025 | 1.727 (1.069-2.790) | 0.074 | 1.524 (0.960-2.420) |
T2 | 15 | Â | Â | Â | Â |
T3 | 80 | Â | Â | Â | Â |
T4 | 105 | Â | Â | Â | Â |
N stage | Â | <0.001 | 2.569 (1.801-3.665) | 0.024 | 2.101 (1.104-3.997) |
N0 | 96 | Â | Â | Â | Â |
N1 | 75 | Â | Â | Â | Â |
N2 | 29 | Â | Â | Â | Â |
Prognostic signature | Â | <0.001 | 7.445 (3.835-14.454) | <0.001 | 6.752 (3.347-13.622) |
High risk | 83 | Â | Â | Â | Â |
Low risk | 117 | Â | Â | Â | Â |